Celesq® Attorneys Ed Center

Navigating Venue and Multi-District Litigation in Hatch-Waxman Cases

Program Number: 3177

Program Date: 04/22/2021


In Valeant Pharmaceuticals v. Mylan Pharmaceuticals, the Federal Circuit clarified venue for Hatch-Waxman cases by holding that infringement only occurs where the ANDA filer took actions related to its ANDA submission, thereby resolving a split among district courts post-TC Heartland. This webinar will address the impact of Valeant on Hatch-Waxman litigation, including how it affects where cases can be filed and litigated. The webinar will also explain how litigants can use multi-district litigation to consolidate pre-trial proceedings in Hatch-Waxman cases, and discuss common issues that arise in multi-district patent litigation.

$95.00Audio Tape Add to Cart

Available in states

California, Colorado Eligible, Florida, Georgia, New Jersey Eligible, New York, Texas Self Study

Credit Information

50 minute credit hour - 1.00 General CLE credit
60 minute credit hour - 1.00 General CLE credit

State Program Numbers


Stanley E. Fisher, Esq.

Williams & Connolly LLP

Stan Fisher is a trial lawyer and counselor who focuses his practice primarily on issues that affect technology companies in the biopharmaceutical, chemical, diagnostic, mechanical, and electronic sectors. Stan has tried numerous cases, before judges and juries in federal and state courts, before arbitration panels, and in the PTAB, on behalf of many of the world’s largest biopharma, medical device and high technology companies in litigation involving patent, FDA, and antitrust disputes and issues, as well as matters involving contracts, licensing, and business torts. He also has an active practice litigating trade secrets, trademarks, and copyrights.

IAM Patent 1000 recognized Stan as a “Leading Patent Litigation Attorney” in its 2020 edition. The publication noted Stan has “broad horizons as a trial lawyer and litigates with confidence and poise in diverse technical fields, across all areas of intellectual property and in regulatory, antitrust and contract disputes.” Stan is a recent Past President of the Giles S. Rich American Inn of Court, the Intellectual Property Inn of Court in Washington, D.C. generally affiliated with the U.S. Court of Appeals for the Federal Circuit. He was named a "Super Lawyer" in 2016-2017 and a Washington, D.C. “Rising Star” for intellectual property in 2014 by Super Lawyers, a rating service affiliated with Reuters.

Stan serves as Professorial Lecturer in Law at The George Washington University Law School, where he teaches Chemical & Biotech Patent Law, a course focused on patent, regulatory, and antitrust issues arising in Hatch-Waxman, BPCIA, and other pharmaceutical and biotechnology patent matters.

Stan received his B.S. in Molecular Biophysics & Biochemistry from Yale College in 1997 and his J.D. from The George Washington University Law School in 2004, where he graduated with Highest Honors and served as Editor-in-Chief of The George Washington Law Review. He joined Williams & Connolly in March 2006 after clerking for Judge Richard Linn at the U.S. Court of Appeals for the Federal Circuit. Stan is a current member of the firm's Budget Committee and former member of the Hiring Committee.


Michael Xun Liu, Esq.

Williams & Connolly LLP

Michael Liu focuses his practice on intellectual property disputes and patent litigation, primarily in the life science industry. Michael has handled every stage of patent litigation, from complaint through trial. In addition to litigating district court cases, Michael has represented clients in IPRs before the U.S. Patent and Trademark Office and in appeals before the U.S. Court of Appeals for the Federal Circuit. Michael has also published articles on the role of post-grant proceedings in U.S. patent disputes, which have appeared in the Journal of Intellectual Property Law and the Baylor Law Review.

Prior to joining Williams & Connolly, Michael clerked for Judge Todd M. Hughes of the U.S. Court of Appeals for the Federal Circuit. Michael graduated magna cum laude from the University of Michigan Law School in 2014, and holds a Master’s degree in Biomedical Engineering from Tulane University. Michael’s graduate research focused on the design of low-cost diagnostic devices.